Tocqueville Asset Management L.P. Mirati Therapeutics, Inc. Transaction History

Tocqueville Asset Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $151,640 - $301,940	-2,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$72.01 - $120.39 $144,020 - $240,780	2,000 New	2,000 $228,000
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $139,560 - $232,420	-2,000 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$70.76 - $128.86 $141,520 - $257,720	2,000 New	2,000 $258,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.